Swiss National Bank’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Swiss National Bank’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-219,100	Closed	-$920K	–	2704
2023 Q1	$920K	Sell	219,100 -1,900	-0.9%	-$9.86K	﹤0.01%	2301
2022 Q4	$1.33M	Buy	+221,000	New	+$1.21M	﹤0.01%	2170
2016 Q2	–	Sell	-36,015	Closed	-$185K	–	2654
2016 Q1	$185K	Buy	36,015 +10,665	+42%	+$85.2K	﹤0.01%	2565
2015 Q4	$312K	Hold	25,350	–	–	﹤0.01%	2472
2015 Q3	$370K	Buy	25,350 +2,760	+12%	+$47.7K	﹤0.01%	2326
2015 Q2	$441K	Buy	22,590 +1,690	+8%	+$32.6K	﹤0.01%	2296
2015 Q1	$378K	Buy	20,900 +1,840	+10%	+$41.4K	﹤0.01%	2321
2014 Q4	$450K	Hold	19,060	–	–	﹤0.01%	2237
2014 Q3	$461K	Buy	19,060 +5,020	+36%	+$131K	﹤0.01%	2152
2014 Q2	$395K	Buy	+14,040	New	+$422K	﹤0.01%	2285

Other funds holding CTIC

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Swiss National Bank's CTIC Position: Q2 2023 in Review

Swiss National Bank sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 219,100 shares — an estimated $920K sold.

Swiss National Bank first reported a position in CTIC in Q2 2014 and held it in 10 quarters. The position peaked at $1.33M in Q4 2022. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.

Swiss National Bank reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
Swiss National Bank sold 219,100 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $920K.
Swiss National Bank first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2014 and held it in 10 quarters.
Swiss National Bank's CTI BioPharma Corp. (DE) Common Stock position peaked at $1.33M in Q4 2022.
2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.

Based on Swiss National Bank's 13F filing for Q2 2023, filed 9 Aug 2023.